Milind Deshpande
2009
In 2009, Milind Deshpande earned a total compensation of $540K as President, Research and Development and Chief Scientific Officer at Achillion Pharmaceuticals, a 32% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $90,957 |
---|---|
Option Awards | $141,000 |
Salary | $303,190 |
Other | $4,841 |
Total | $539,988 |
Deshpande received $303.2K in salary, accounting for 56% of the total pay in 2009.
Deshpande also received $91K in non-equity incentive plan, $141K in option awards and $4.8K in other compensation.
Rankings
In 2009, Milind Deshpande's compensation ranked 6,597th out of 9,885 executives tracked by ExecPay. In other words, Deshpande earned more than 33.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 6,597 out of 9,885 | 33rd |
Division Manufacturing | 2,418 out of 3,690 | 35th |
Major group Chemicals And Allied Products | 531 out of 866 | 39th |
Industry group Drugs | 362 out of 638 | 43rd |
Industry Pharmaceutical Preparations | 258 out of 446 | 42nd |
Source: SEC filing on April 16, 2012.
Deshpande's colleagues
We found five more compensation records of executives who worked with Milind Deshpande at Achillion Pharmaceuticals in 2009.
2009
Michael Kishbauch
Achillion Pharmaceuticals
Chief Executive Officer
2009
Joseph Truitt
Achillion Pharmaceuticals
Senior Vice President and Chief Commercial Officer
2009
Gautam Shah
Achillion Pharmaceuticals
Senior Vice President and Chief Compliance Officer
2009
Elizabeth Olek
Achillion Pharmaceuticals
Chief Medical Officer
2009
Mary Fenton
Achillion Pharmaceuticals